Although sales and profit figures are unknown, the company has resolved to apply for a market category change to the Standard Market. The current issue of market capitalization relative to tradable shares continuing to fail to meet Prime Market criteria is a persistent challenge, and after evaluating maintaining Prime Market, the company announced its plan to transition to the Standard Market.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4574","jir_company_name":"Taiho Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4574-20260825-01.pdf","jir_short_summary":"Although sales and profit figures are unknown, the company has resolved to apply for a market category change to the Standard Market. The current issue of market capitalization relative to tradable shares continuing to fail to meet Prime Market criteria is a persistent challenge, and after evaluating maintaining Prime Market, the company announced its plan to transition to the Standard Market.","jir_summary":"### Section Heading\nThis is a notice regarding the application for market category change to the Tokyo Stock Exchange Standard Market. After a period of inadequate alignment with the market capitalization criteria for the Prime Market as of the end of 2023, the company submitted an alignment plan in 2024, and in the following year remained out of compliance. While improvements have been pursued, from the perspective of long-term management strategy and shareholder value maximization, the decision was made to emphasize suitability for the Standard Market and to proceed with the market category change application. If any matters requiring disclosure arise in the future, they will be published promptly.\n\n### Section 2 Background\nThe background of the market category change resolution is to reassess the suitability of the current corporate size and growth stage for the market category, aiming for ongoing compliance and optimal resource allocation. Rather than pursuing Prime Market eligibility at all costs, the company intends to shift to the Standard Market to pursue long-term growth and enhanced corporate value. Moving forward, related disclosures will be made as appropriate to maximize shareholder and stakeholder interests.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#TaihoPharmaceutical Co., Ltd., #MarketCategoryChange, #TransitionToStandardMarket","jir_key_figures":"Market category change application resolution: Unknown\nCurrent market capitalization of tradable shares: Unknown\nPlan to submit\/publish improvement period: March 24, 2025, with further disclosures to follow","jir_meta_title":"\u3010Taiho Pharmaceutical Co., Ltd.\u3011Notice of Market Category Change Application\uff5cAugust 25, 2026","jir_meta_description":"Taiho Pharmaceutical has applied for a market category change to the Tokyo Stock Exchange Standard Market. The description covers alignment with market capitalization, future disclosure policy, and strategy for maximizing shareholder value. Please refer to the main text for details.","jir_og_title":"\u3010Taiho Pharmaceutical Co., Ltd.\u3011Notice of Market Category Change Application","jir_og_description":"Taiho Pharmaceutical applies for a market category change to the Standard Market. The company outlines its policy from a management strategy and shareholder value maximization perspective. Future disclosure plans are also noted.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58317,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-106855","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n